In parts of the world, the Ozempic patent has expired this year. Generic manufacturers from emerging markets are benefiting from this, which are preparing for market opening in the US and Europe. WORLD presents the most promising candidates.
Starbucks reduced coverage for Ozempic-type drugs, as employer spending on popular GLP-1 drugs soars The post High prices of Ozempic-type drugs are reshaping corporate health plans appeared first on in.gr.